Table 2. Intracellular localization of Bid-EYFP, tBid-EYFP and its deletion mutants.
Construct | EYFP/TRME | Localization |
tBid | 1±0,07 | Mitochondrial |
tBidE94G | 1±0,07 | Mitochondrial |
tBidΔBH3 | 1±0,07 | Mitochondrial |
tBidΔH6 | 0,53±0,05 | Cytoplasmic |
tBidΔH6–H7 | 0,30±0,03 | Cytoplasmic |
tBidΔH6–8 | 0,27±0,03 | Cytoplasmic |
tBidΔBH3ΔH6–8 | 0,27±0,03 | Cytoplasmic |
tBidKK157,158AA | 0,94±0,40 | Mitochondrial* |
tBidE94G,KK157,158AA | 0,94±0,54 | Mitochondrial* |
tBidΔH3, or ΔH4, or ΔH5, or ΔH7, or ΔH8 | 0,97±0,09 | Mitochondrial |
CV-1 cells were transfected with plasmids encoding Bid-EYFP, tBid-EYFP or tBid-EYFP mutants in presence of 10 µM of Bok-D. 24 h later, cells were stained with 20 nM of the mitochondrial potential probe TMRE and the localization of the tBid-EYFP mutants was determined by calculation of the TMRE/EYFP ratios using microspectrofluorometry. A ratio of 1.0 indicates that EYFP exclusively colocalizes with TMRE at the mitochondria while a lower ratio indicates that EYFP is also localized to the cytosol. The * highlights the contructs that localize to the mitochondria but are unable to induce cytochrome c release or to alter mitochondrial bioenergetics. The constructs that localize to the cytoplasm are in italic.